OncLive - Bringing the Oncology Community Together

Home

Targeted Therapies

Hennessy's Highlights

January 2012

Academy

John Theurer Cancer Center at Hackensack University Medical Center: Providing Extraordinary Care to the Community

Breast Cancer

Concurrent Zoledronic Acid Is Preferable in Letrozole-Treated Postmenopausal Patients With Breast Cancer

Clinical Trial Reports

January 2012: Trials in Progress

Transplant Recipients Have Higher Risk of Diverse Cancers

Radiation Added to Hormone Therapy Bests Hormone Therapy Alone for High-Risk Prostate Cancer

Breast Cancer is Diagnosed Later in Men but Is Less Often Fatal

Navigation Program Shows Limited Benefit in Underserved, Urban Women With Breast Cancer

Outpatient Treatment Approved for Low-Risk Febrile Neutropenia

Premature Tamoxifen Withdrawal Is Common in Male Patients With Breast Cancer

Conference Highlights

Treatment of Large Cell Lymphoma: R-CHOP and Beyond

Novel Therapeutics Have Revolutionized Multiple Myeloma Treatment

The Prostate Cancer Microenvironment: Implications for Therapy

Role of Bisphosphonate Therapy Refined but Still More Questions

Anastrozole Plus Fulvestrant Improved Survival in Metastatic Hormone Receptor-Positive Breast Cancer

Feature Article

HPV and the Rise of Head and Neck Cancers

Targeted Therapies Yield Most Promising Results: A New Era in Melanoma Treatment Has Begun

From the Editor

News

Mouth Care Systems Alleviate Xerostomia After Radiotherapy

Melanoma Breakthroughs Among Top 2011 Cancer Advances

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.